Navigation auf zora.uzh.ch

Search ZORA

ZORA (Zurich Open Repository and Archive)

FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma

Abstract

Extraventricular neurocytoma (EVN) is a rare primary brain tumor occurring in brain parenchyma outside the ventricular system. Histopathological characteristics resemble those of central neurocytoma but exhibit a wider morphologic spectrum. Accurate diagnosis of these histologically heterogeneous tumors is often challenging because of the overlapping morphological features and the lack of defining molecular markers. Here, we explored the molecular landscape of 40 tumors diagnosed histologically as EVN by investigating copy number profiles and DNA methylation array data. DNA methylation profiles were compared with those of relevant differential diagnoses of EVN and with a broader spectrum of diverse brain tumor entities. Based on this, our tumor cohort segregated into different groups. While a large fraction (n = 22) formed a separate epigenetic group clearly distinct from established DNA methylation profiles of other entities, a subset (n = 14) of histologically diagnosed EVN grouped with clusters of other defined entities. Three cases formed a small group close to but separated from the epigenetically distinct EVN cases, and one sample clustered with non-neoplastic brain tissue. Four additional samples originally diagnosed otherwise were found to molecularly resemble EVN. Thus, our results highlight a distinct DNA methylation pattern for the majority of tumors diagnosed as EVN, but also indicate that approximately one third of morphological diagnoses of EVN epigenetically correspond to other brain tumor entities. Copy number analysis and confirmation through RNA sequencing revealed FGFR1-TACC1 fusion as a distinctive, recurrent feature within the EVN methylation group (60%), in addition to a small number of other FGFR rearrangements (13%). In conclusion, our data demonstrate a specific epigenetic signature of EVN suitable for characterization of these tumors as a molecularly distinct entity, and reveal a high frequency of potentially druggable FGFR pathway activation in this tumor group.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Neuropathology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Scopus Subject Areas:Health Sciences > Pathology and Forensic Medicine
Health Sciences > Neurology (clinical)
Life Sciences > Cellular and Molecular Neuroscience
Uncontrolled Keywords:Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Clinical Neurology
Language:English
Date:5 July 2018
Deposited On:19 Jul 2018 09:48
Last Modified:18 Jan 2025 02:40
Publisher:Springer
ISSN:0001-6322
OA Status:Closed
Publisher DOI:https://doi.org/10.1007/s00401-018-1882-3
PubMed ID:29978331

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
59 citations in Web of Science®
64 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 19 Jul 2018
0 downloads since 12 months

Authors, Affiliations, Collaborations

Similar Publications